Considering the role of the serotonin and angiotensin systems in cardiac hypertrophy, we hypothesized that DNA variants in the 5-HT2A, 5-HTT, AGT, ACE, and AT1R genes could influence the risk for LVH. This evidence concerns the gene AGTR1 and cardiac hypertrophy.